Trials / Conditions / Advanced Non-squamous NSCLC
Advanced Non-squamous NSCLC
6 registered clinical trials studyying Advanced Non-squamous NSCLC.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non S NCT06879717 | iOnctura | Phase 1 / Phase 2 |
| Unknown | Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy NCT04670913 | Junling Li | Phase 2 |
| Terminated | A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATI NCT04325698 | Pfizer | Phase 3 |
| Unknown | Study of Anlotinib in Advanced Non-squamous NSCLC Patients in the Elderly Without Systemic Chemotherapy (ALTER NCT03778853 | LanZhou University | Phase 4 |
| Unknown | Anlotinib Plus Pemetrexed or Pemetrexed for Previously Untreated Elderly (>=70) or PS=2 Non-squamous NSCLC NCT03768037 | Guangdong Association of Clinical Trials | Phase 4 |
| Terminated | A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC NCT00369070 | Amgen | Phase 2 |